Outlook Therapeutics (41O) Revenue

8 Followers

Outlook Therapeutics Revenue

Outlook Therapeutics had a revenue of 127.44K in the quarter ending Mar 31, 2026, with 110.55%. This bring the company's revenue in the last twelve months to 333.14K, Decreased 61.95%. In the fiscal year ending Sep 30, 2025, Outlook Therapeutics had annual revenue of 1.41M with Infinity% growth.

Revenue (ttm)

333.14K

Revenue Growth

―

P/S Ratio

119.26

Revenue/Employee

€83,149

Employees

Market Cap

€168.57M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Sep 30, 2025	1.41M	―	+∞%
Sep 30, 2024	―	―	―
Sep 30, 2023	―	―	―
Sep 30, 2022	―	―	―
Sep 30, 2021	―	―	―
Sep 30, 2020	―	-8.15M	-100.00%
Sep 30, 2019	8.15M	5.06M	+163.80%
Sep 30, 2018	3.09M	-724.00K	-18.99%
Sep 30, 2017	3.81M	―	―